Cellular uptake of NU-0129 in glioma cells correlated with a reduction in Bcl2L12 protein expression, as indicated by comparing matched primary tumors and NU-0129-treated recurrent tumors. The gene discussed is PSMA1; the disease is central nervous system cancer.